Inflammation markers after randomization to abacavir/lamivudine or tenofovir/emtricitabine with efavirenz or atazanavir/ritonavir: ACTG A5224 s, A5202 substudy

BACKGROUND: The effect of specific antiretrovirals on inflammation is unclear. METHODS: A5224 s was a substudy of A5202, which randomized HIV-infected treatment-naïve subjects to blinded abacavir/lamivudine (ABC/3TC) or tenofovir/emtricitabine (TDF/FTC) with open-label efavirenz (EFV) or atazanavir/...

Full description

Saved in:
Bibliographic Details
Main Authors: McComsey, Grace A., Kitch, Douglas, Daar, Eric S., Tierney, Camlin, Jahed, Nasreen C, Melbourne, Kathleen, Ha, Belinda, Brown, Todd T., Bloom, Anthony, Fedarko, Neal, Sax, Paul E.
Format: Artigo
Language:Inglês
Published: 2012
Subjects:
Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC3560932/
https://ncbi.nlm.nih.gov/pubmed/22546988
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/QAD.0b013e328354f4fb
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items